
Phase II Study of Arimoclomol in IBM FDA-OOPD
Author(s) -
Mazen M. Dimachkie,
Michael G. Hanna,
Pedro Machado,
Laura Herbelin,
Mamatha Pasnoor,
Omar Jawdat,
April McVey,
Jeffery Statland,
Melanie Glenn,
Linda Greensmith,
Bill Martens,
Rabi Tawil,
Michael P. McDermott,
Richard J. Barohn
Publication year - 2021
Publication title -
rrnmf neuromuscular journal
Language(s) - English
Resource type - Journals
ISSN - 2692-3092
DOI - 10.17161/rrnmf.v2i3.15728
Subject(s) - ibm , mathematics , materials science , nanotechnology